Education
About Us
Working with TipRanks
Follow Us
Psyence Group Inc. (TSE:PSYG)
:PSYG
PSYG Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.11 - C$0.53
Previous CloseN/A
Volume20.00K
Average Volume (3M)1.92K
Market Cap
C$2.66M
Enterprise ValueC$26.22M
Total Cash (Recent Filing)C$1.11M
Total Debt (Recent Filing)C$12.41M
Price to Earnings (P/E)―
Beta0.25
Next Earnings
Sep 01, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding15,638,267
10 Day Avg. Volume3,606
30 Day Avg. Volume1,924
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Psyence Group News
PSYG FAQ
What was Psyence Group Inc.’s price range in the past 12 months?
Psyence Group Inc. lowest stock price was C$0.10 and its highest was C$0.53 in the past 12 months.
What is Psyence Group Inc.’s market cap?
Psyence Group Inc.’s market cap is C$2.66M.
When is Psyence Group Inc.’s upcoming earnings report date?
Psyence Group Inc.’s upcoming earnings report date is Sep 01, 2025 which is in 24 days.
How were Psyence Group Inc.’s earnings last quarter?
Currently, no data Available
Is Psyence Group Inc. overvalued?
According to Wall Street analysts Psyence Group Inc.’s price is currently Overvalued.
Does Psyence Group Inc. pay dividends?
Psyence Group Inc. does not currently pay dividends.
What is Psyence Group Inc.’s EPS estimate?
Psyence Group Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Psyence Group Inc. have?
Psyence Group Inc. has 15,638,267 shares outstanding.
What happened to Psyence Group Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Psyence Group Inc.?
Currently, no hedge funds are holding shares in TSE:PSYG
Company Description
Psyence Group Inc.
Psyence Group (PSYG) is a biotechnology company focused on advancing psychedelic therapy and natural-based medicine. The company operates in the life sciences sector, leveraging the therapeutic potential of psychedelic compounds to address mental health issues and neurological disorders. Psyence’s core products and services include the development of natural psilocybin-based therapies, cultivating and processing psilocybin mushrooms, and conducting clinical trials to establish the efficacy and safety of their treatments.
Technical Analysis
Ownership Overview
0.82% Insiders
―
Mutual Funds
― Other Institutional Investors
99.18% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---